Aurinia Pharmaceuticals AUPH Total costs & expenses

Total costs & expenses at other companies

ANI PharmaceuticalsANIP

$225.58M+14.2%

Opko HealthOPK

$170.55M-21.3%

LQD

Liquidia CorporationLQDA

$86.16M+85.9%

Zevra Therapeutics, Inc.ZVRA

$21.05M-13.1%

ALN

Alnylam PharmaceuticalsALNY

$1.06B+34.1%

BridgeBio PharmaBBIO

$350.76M+43.3%

FAQ

What is Aurinia Pharmaceuticals's total costs & expenses?

Aurinia Pharmaceuticals (AUPH) reported total costs & expenses of $36.88M in Q2 2026.

How has Aurinia Pharmaceuticals's total costs & expenses changed year-over-year?

Aurinia Pharmaceuticals's total costs & expenses decreased by 26.1% year-over-year, from $49.93M to $36.88M.

What is the long-term trend for Aurinia Pharmaceuticals's total costs & expenses?

Over 4 years (2021 to 2025), Aurinia Pharmaceuticals's total costs & expenses has grown at a -5.8% compound annual growth rate (CAGR), from $226.34M to $178.14M.

What does total costs & expenses mean?

This metric represents the aggregate sum of all operating and non-operating costs incurred by the company to generate revenue and maintain business operations during a specific period. It encompasses cost of goods sold, research and development expenditures, and selling, general, and administrative expenses. Monitoring this figure allows stakeholders to evaluate the company's overall cost structure and operational efficiency relative to its revenue generation.